The future of stromectol lies in ongoing research and innovation aimed at expanding its therapeutic indications, optimizing its pharmacological properties, and addressing emerging challenges such as drug resistance and environmental sustainability. Advances in drug delivery technologies, pharmacogenomics, and precision medicine offer promising avenues for enhancing the efficacy, safety, and accessibility of ivermectin for humans-based therapies. By harnessing the full potential of stromectol, we can continue to make meaningful strides towards achieving global health equity and eliminating the burden of parasitic diseases.
